Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 23, 2026.

Branching Out: Alterations in Bacterial Physiology and Virulence Due to Branched-Chain Amino Acid Deprivation

Julienne C. Kaiser, David E. Heinrichs

mBio · 2018 · Review · CC BY

doi:10.1128/mbio.01188-18

Abstract

The branched-chain amino acids (BCAAs [Ile, Leu, and Val]) represent important nutrients in bacterial physiology, with roles that range from supporting protein synthesis to signaling and fine-tuning the adaptation to amino acid starvation. In some pathogenic bacteria, the adaptation to amino acid starvation includes induction of virulence gene expression: thus, BCAAs support not only proliferation during infection, but also the evasion of host defenses.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 23, 2026. Paragraph numbers are ours, so an answer can point at one.

BACTERIAL ADAPTATION TO NUTRIENT AVAILABILITY

Bacteria sense a variety of physical and chemical signals in their environment and use this information to coordinate an adaptive response that promotes their growth and survival. These signals include nutrients such as sugars, lipids, metals, and amino acids, and their depletion triggers upregulation of high-affinity nutrient acquisition systems and/or biosynthesis pathways. Nutrient availability is also an important environmental cue during infection, as pathogens encounter fluctuating nutrient access in a host and must adapt their metabolism accordingly to proliferate and avoid being cleared. Host environments impose an added challenge by actively sequestering nutrients to limit pathogen growth. To cope, pathogens release toxins that act to liberate nutrients from host tissues. In this way, virulence determinant production is tied to the nutrient composition of a given host niche.

Several transcriptional regulators are positioned at the intersection of metabolism and pathogenesis, such as CcpA (responds to a preferred carbon source), CodY (responds to GTP and branched-chain amino acids [BCAAs]), and RpiR (responds to pentose phosphate pathway intermediates). The relevance of such regulators to gross bacterial physiology is typically evidenced by mutating the regulator and measuring transcriptional changes to identify shifts in metabolism that presumably allow the pathogen to adapt to restriction of a given nutritional signal. This approach assumes that adaptive responses are binary, with each category defined by a completely active or inactive regulator. This methodology, however, fails to capture the intermediate responses that occur along a gradient of nutrient concentrations, which are more likely to represent the conditions pathogens encounter in vivo. It has remained challenging to capture the adaptive responses along a spectrum of nutrient availability because the mechanisms pathogens use to obtain nutrients, which therefore dictate this spectrum, are often unknown. Without a good understanding of the mechanisms that influence intracellular levels of regulatory nutrients, it remains largely unanswered how pathogens fine-tune intracellular nutrient pools at levels that are sufficient to promote growth in host tissues, while still allowing the bacteria to maintain sensitivity to changes in their external environment.

Several recent studies have applied a novel approach to address these gaps and have characterized the adaptive responses that correspond to graded nutritional levels. This approach, applied to the CodY regulator, involves mutating the effector binding site to mimic graded nutrient depletion, resulting in protein variants with fixed activation states along the full spectrum of CodY activity. Readers are directed to a recent review by Brinsmade for a detailed summary of these studies. Comparison of the transcriptomes of cells bearing each protein variant has revealed that CodY-regulated genes are expressed as a hierarchy, whereby some target genes are derepressed upon a slight reduction of CodY activity, whereas other target genes remain repressed under the same conditions and are derepressed only upon a more significant reduction of CodY activity. These studies reveal the sensitivity of important physiological responses, including virulence gene expression, to changes in intracellular nutrient availability, namely BCAA concentrations. This has renewed interest in characterizing the factors that dictate intracellular BCAA concentrations, such as endogenous synthesis and acquisition mechanisms, and in investigating the relative contribution of these mechanisms to supplying BCAAs at key threshold concentrations that define a microorganism’s physiological state. In this review, we will discuss the roles of BCAAs in bacterial physiology, the mechanisms of biosynthesis and transport, and the recent advancements made in understanding how depletion of intracellular sources impacts pathogen proliferation and adaptation in host niches, with a focus on the role of BCAAs in regulating CodY. Although CodY is found only in Gram-positive bacteria, we will nonetheless discuss BCAA metabolism in both Gram-negative and Gram-positive bacteria to highlight shared physiological roles and mechanisms of acquisition and biosynthesis.

MULTIFACETED ROLE FOR BRANCHED-CHAIN AMINO ACIDS IN BACTERIAL PHYSIOLOGY

The BCAAs are small nonpolar amino acids with branched alkyl side chains that make them hydrophobic and confer unique properties in proteins. Leu is a strong stabilizer of α-helical structures and, as such, is typically found in the inner helical core of proteins, whereas the substitution of the β-carbon with a methyl group on Ile and Val creates bulkiness that destabilizes α-helical structures; thus, Ile and Val are preferentially located in β-sheets.

Bacteria synthesize BCAAs through a conserved pathway that is present in fungi and plants, but absent in mammals. The level of synthesis is dependent on the availability of metabolites linked to central metabolism, including pyruvate, acetyl coenzyme A (acetyl-CoA), and oxaloacetate (Fig. 1). The biosynthetic pathway also provides intermediates for the synthesis of vitamin B5 (pantothenate) and branched-chain fatty acids (BCFAs) (Fig. 1). BCFAs are the predominant fatty acids in Gram-positive bacterial membranes, and the nature and abundance of specific BCFAs determine the biophysical properties of the membrane. This contrasts with Gram-negative bacteria, where the predominant fatty acids are straight-chain fatty acids (SCFAs) and the biophysical properties of the membrane are determined by the degree of saturation. SCFA and BCFA synthesis proceeds through the same multienzyme fatty acid synthesis (FAS-II) pathway; however, the substrates that initiate the pathway differ. Acetyl-CoA serves as the substrate for SCFA synthesis, whereas branched-chain acyl-CoA serves as the substrate for BCFA synthesis. When initiated with branched-chain acyl-CoA substrates, the pathway produces even-chain anteiso-FAs derived from Ile, even-chain iso-FAs derived from Leu, and odd-chain iso-FAs derived from Val. Regulation of the ratio of iso to anteiso fatty acids and/or SCFA to BCFA facilitates adaptation to changes in temperature, pH, salinity, and CO2. The positioning of the methyl group on the acyl chain of anteiso-FAs disrupts close packing of membrane lipids, promoting a more fluid membrane. This property is critical to adaptation to growth at low temperatures, during which the anteiso-FA (namely, a15:0) content is increased. Thus, the importance of BCAAs for bacterial physiology stems from their integration with central metabolism, their requirement for protein synthesis, and their requirement for environmental adaptation via BCFA synthesis in Gram-positive bacteria.

BCAAs AS INDICATORS OF CELLULAR METABOLIC STATUS

In addition to their physiological roles, the BCAAs are effectors of the global transcriptional regulators leucine-responsive regulatory protein (Lrp) in Gram-negative bacteria and CodY in Gram-positive bacteria. These global regulators coordinate the response to nutrient availability and regulate metabolic reprogramming to sustain growth upon nutrient exhaustion, as exemplified by the characteristic metabolic shift to stationary phase under laboratory growth conditions (Fig. 2). This transition coincides with accumulation of (p)ppGpp, a metabolite synthesized from GTP during the stringent response, a response provoked by amino acid starvation.

Lrp is a highly conserved transcriptional regulator in enteric bacteria and regulates gene expression upon entry into stationary phase. Lrp DNA-binding activity is enhanced, antagonized, or not affected by Leu availability, depending on the target gene, and binding can lead to either transcriptional repression or activation. Its target genes include those involved in glutamate, glutamine, BCAA, and serine biosynthesis, glycine degradation, BCAA and oligopeptide transport, and pilus formation. CodY, a conserved transcriptional regulator in low-GC Gram-positive bacteria (i.e., Firmicutes), senses the metabolic status of the cell to promote adaptation to nutrient limitation. CodY is activated through direct interaction with BCAAs and GTP, with the exception of Lactococcus lactis and Streptococcus pneumoniae, where CodY responds to only BCAAs. In its active state, CodY binds to DNA, typically leading to transcriptional repression, although direct activation has been observed involving an unknown mechanism. Thus, in general, CodY target genes are repressed during rapid growth and expressed upon nutrient deprivation. CodY regulates metabolic genes involved in amino acid synthesis, purine biosynthesis, sugar and amino acid transport, and the Krebs cycle, as well as, in some species, sporulation and biofilm formation. CodY also regulates virulence gene expression in Gram-positive pathogens, including Bacillus anthracis, Bacillus cereus, Clostridium difficile, Clostridium perfringens, Listeria monocytogenes, Staphylococcus aureus, S. pneumoniae, and Streptococcus pyogenes. The role of CodY as a regulator of metabolism and virulence has been comprehensively reviewed elsewhere; thus, readers are directed to several recent reviews for more information.

The accumulation of (p)ppGpp and consequential depletion of GTP impact the regulatory responses of Lrp and CodY, respectively, thereby linking these regulators to the stringent response (Fig. 2). Accumulation of (p)ppGpp induces lrp expression, and depletion of GTP decreases CodY DNA-binding activity. In Betaproteobacteria and Gammaproteobacteria, the relative levels of (p)ppGpp and GTP are controlled by the synthetase RelA, which converts GTP to (p)ppGpp, and the hydrolase SpoT, which reverses the reaction. In other genera, a single bifunctional enzyme, RSH (RelA/SpoT homologue [or Rel]), interconverts (p)ppGpp and GTP. Recently, BCAAs were found to regulate the accumulation of (p)ppGpp. In Alphaproteobacteria, Val and Ile bind and activate the domain of the RSH that is responsible for hydrolyzing (p)ppGpp to GTP. Thus, the stringent response is countered under conditions of high BCAAs and promoted under conditions of BCAA limitation. This regulatory mechanism might also occur in other bacteria, as Val binds to the RelA enzyme in Gammaproteobacteria and Leu binds to the RSH enzyme in Gram-positive bacteria. Thus, BCAAs influence Lrp and CodY regulatory responses directly by binding and regulating their DNA-binding activity, and indirectly by regulating (p)ppGpp hydrolysis to GTP.

An emerging role for isoleucine in regulating Gram-positive environmental adaptation.

Historically, all three BCAAs have been considered equal CodY effectors. Indeed, all three bind to CodY and activate its DNA-binding activity, and yet, some studies have observed a stronger effect of Ile on CodY DNA-binding activity than either Leu or Val. A predominant role for Ile in regulating CodY activity during growth has also emerged. Depletion of Ile and not Leu or Val relieves repression of CodY-regulated genes in B. subtilis, L. monocytogenes, and S. aureus. Furthermore, as CodY target genes tend to comprise metabolic pathways, such as amino acid biosynthesis, the levels of Ile in the growth medium consequentially impact growth rate. Addition of excess Ile to the growth medium impairs growth of L. lactis, Streptococcus mutans, and S. aureus, whereas Ile depletion has the opposite effect. S. aureus growth is significantly impaired in media lacking Leu; however, its growth is restored upon simultaneous Ile and Leu depletion. An S. mutans mutant that is unable to synthesize (p)ppGpp (i.e., mimicking a strain with constitutively active CodY) is not able to grow in media lacking Leu or Val, but is able to grow in media lacking Ile, Leu, and Val. These growth restoration phenotypes are most likely CodY dependent, requiring Ile depletion to relieve CodY repression of amino acid biosynthesis. Given that the results of DNA-binding assays are influenced by the conditions tested (i.e., pH or salt), the growth assays are likely a more accurate representation of intracellular conditions. As such, this would suggest that, inside the cell, Ile is the predominant BCAA to affect CodY activity. When considered in the context of Gram-positive pathogens, in which CodY also regulates virulence gene expression, this suggests that Ile could serve as a host metabolic cue. Indeed, Ile availability influences virulence gene expression in L. monocytogenes and S. aureus (discussed in more detail below). These advances have renewed interest in the factors that influence intracellular availability of Ile (and BCAAs in general) to better understand how pathogens scavenge BCAAs and where in the host they encounter BCAA limitation.

BCAA biosynthesis.

BCAAs are synthesized through a conserved pathway in Gram-negative and Gram-positive bacteria (Fig. 1), with the exception of the BCAA auxotrophs Erysipelothrix rhusiopathiae, Mycoplasma spp., Ureaplasma spp., Peptostreptococcus anaerobius, Streptococcus pyogenes, and Streptococcus agalactiae. For detailed biochemical descriptions of each of the biosynthetic enzymes and regulation of their activity, readers are directed to a recent review by Amorim Franco and Blanchard.

The Leu biosynthetic genes are typically clustered in an operon (leuABCD) that may be either separate from the ilv genes or organized in a single ilv-leu operon, depending on the species. Several mechanisms of transcriptional regulation of these genes have been described, many involving transcriptional repression in response to BCAA availability. In Gram-negative bacteria, this is primarily mediated by attenuation. The attenuator region precedes the operon and is transcribed with the biosynthetic operon. It encodes a small BCAA-rich peptide, and as such, its rate of translation is determined by BCAA availability. When BCAA levels are high, the peptide is readily translated, allowing for a terminator secondary structure to form, which terminates transcription. When BCAA levels are low, the peptide is translated slowly, promoting an antiterminator secondary structure to form, allowing transcription to proceed. In Escherichia coli, the expression of many of the BCAA biosynthetic genes (organized as ilvGMEDA, leuABCD, ilvC, ilvIH, and ilvBN) is controlled by attenuation. The ilvGMEDA operon is preceded by a 32-amino-acid (aa) peptide that contains 15 BCAAs, ilvBN is preceded by a 32-aa peptide with 11 BCAAs, and the leuABCD operon is preceded by a 28-aa peptide containing 4 Leu. Attenuation is also the primary mechanism of regulating the leu operon in Salmonella enterica serovar Typhimurium and putative leader peptides and terminator hairpins are found upstream of BCAA biosynthesis genes across various Gram-negative species, suggesting that BCAA-dependent attenuation is a conserved mechanism. The biosynthetic genes in E. coli are also regulated by Lrp, which binds to the ilvIH and ilvG promoters in the absence of Leu to activate and repress transcription, respectively.

In Gram-positive bacteria, multiple global regulators coordinate expression of the BCAA biosynthetic operon in response to not only BCAA availability but also carbon and nitrogen availability. In B. subtilis, the single ilv-leu operon is positively regulated by the carbon catabolite protein A (CcpA), a global transcriptional regulator that regulates carbon utilization in response to a preferred carbon source. This positive regulation is antagonized by either TnrA, a regulator that responds to nitrogen limitation, or CodY. Together, this allows for conservation of carbon and nitrogen when exogenous BCAA sources are present. Additional fine-turning of ilv-leu expression is mediated by a Leu-responsive T-box riboswitch, as well as mRNA processing. CodY-dependent repression of BCAA biosynthesis is common across Gram-positive bacteria, whereas TnrA homologues are less conserved. In contrast to the tRNA-mediated attenuation observed in B. subtilis, recent experimental evidence implicates ribosome-mediated attenuation as an important mechanism regulating BCAA biosynthesis in S. aureus and L. monocytogenes. Furthermore, bioinformatics analysis of the leader sequence of the BCAA biosynthetic genes in L. lactis, Corynebacterium glutamicum, and Streptococcus spp. have revealed BCAA-rich peptides and terminator hairpins consistent with attenuation, suggesting that ribosome-mediated attenuation is a common mechanism controlling transcription of the BCAA biosynthetic operon in Gram-positive bacteria. In S. aureus, an additional regulatory mechanism governing BCAA biosynthesis has been described involving repression by the essential Gcp/YeaZ complex. YeaZ binds upstream of the ilv-leu operon, suggesting possible direct repression of the operon, although the conditions that regulate its binding are currently unknown.

The BCAA auxotrophy paradox.

Even in the presence of intact biosynthesis genes, some Gram-positive bacteria synthesize little to no BCAAs in the absence of an exogenous source, with some even being misclassified as auxotrophs. L. monocytogenes synthesizes very little Ile, Leu, and Val despite possessing intact and functional biosynthetic genes. Similarly, S. pneumoniae is unable to grow in a chemically defined medium when Ile, Leu, or Val is omitted. Streptococcus suis exhibits a Leu auxotrophy despite possessing intact Leu biosynthesis genes and synthesizes moderate levels of Val but no detectable Ile. Despite possessing an intact BCAA biosynthetic operon, S. aureus exhibits a significant growth delay in the absence of Leu, and growth in the absence of Val occurs only upon accumulation of suppressor mutations. One possible explanation for an observed “auxotrophy” could be the availability of biosynthetic precursors. L. monocytogenes lacks a 2-oxoglutarate dehydrogenase enzyme and is therefore unable to derive oxaloacetate from the tricarboxylic acid (TCA) cycle (Fig. 1). Instead, L. monocytogenes carboxylates pyruvate to form oxaloacetate in environments where glucose is the sole carbon source. Shortage of this indirect BCAA precursor might explain the limited amounts of BCAAs synthesized in this species. Another possible factor could be tight transcriptional repression of the biosynthetic operon. S. aureus is able to grow in the absence of Val only upon selection of strains with mutations that relieve either CodY-dependent repression or attenuator-dependent repression, indicating that the ilv-leu operon remains under tight repressive control even in the absence of Val. Repression is relieved upon Ile depletion via CodY and to a lesser extent, upon Leu depletion via transcriptional attenuation. Such tight control is also observed in L. monocytogenes, which also regulates BCAA biosynthesis in response to Ile via CodY-dependent repression and a BCAA-rich attenuator peptide.

Specialized BCAA transporters.

The repression of the BCAA biosynthetic genes in response to BCAA availability allows for conservation of carbon and nitrogen when an exogenous source can be acquired. Active transporters specific to BCAAs are common across bacteria and require either ATP or the proton motive force to import BCAAs. BCAA transporters in Gram-negative bacteria include the high-affinity LIV-I system and the low-affinity LIV-II and LIV-III systems (Table 1). LIV-I is an ATP-binding cassette (ABC) transporter encoded by livJKHMGF. Two substrate binding proteins mediate BCAA transport through this system; LIV-B (livJ), which can bind all three BCAAs, and LS-B (livK), which is Leu specific. LIV-II, also known as BrnQ, is a permease with 12 transmembrane helices and belongs to the major facilitator superfamily (MFS). LIV-III is a permease homologous to LIV-II, with transport activity that is obviated only in a LIV-II deficient background in Salmonella Typhimurium and Pseudomonas aeruginosa. LIV-II and LIV-III use energy from the proton motive force to couple BCAA transport with Na+ across an energy gradient. An additional MFS transporter specific to Ile transport and unique to Francisella tularensis has 12 transmembrane helices and belongs to the phagosomal nutrient transporter family of MFS transporters identified in Legionella pneumophila.

BrnQ also functions as a BCAA transporter in Gram-positive bacteria, along with a second nonhomologous permease, BcaP (Table 1). L. lactis acquires BCAAs via both BcaP and BrnQ, with BcaP playing a more predominant role. Similarly, BcaP is the predominant transporter in B. subtilis, with two additional transporters, BrnQ and BraB (a BrnQ homologue), contributing to Ile and Val uptake and an unidentified transporter contributing to Leu uptake. In contrast, BrnQ1 serves as the predominant transporter for S. aureus growth, with BcaP playing a secondary role. S. aureus encodes two additional brnQ homologues: BrnQ2, an Ile-dedicated transporter, and BrnQ3, which has no observed BCAA transport function. A LIV-I system with a substrate binding protein able to bind BCAAs has been described in S. pneumoniae, although no transport function has yet been ascribed to this system. BrnQ also directs BCAA transport in Lactobacillus delbrueckii and C. glutamicum.

Mechanisms that support growth during infection.

BCAA availability at various infection sites remains undefined; however, both BCAA biosynthesis and transport have been linked to promoting the virulence of pathogens during infection, suggesting that pathogens encounter BCAA limitation in vivo. Concentrations of BCAAs have been estimated in some host environments relevant to pathogens. Levels of BCAAs in the bloodstream range from 20 to 92 µM for Ile, 40 to 250 µM for Leu, and 65 to 266 µM for Val. Human nasal secretions contain Leu levels in the range of 130 to 287 µM, Val levels in the range of 13 to 156 µM, and very little or no Ile. Indeed, some pathogens exploit these extracellular BCAA sources during infection. S. aureus requires both the BrnQ1 and BcaP transporters for optimal fitness during systemic infection and nasal colonization. BCAA acquisition also likely contributes to S. aureus lung infection, as transport genes are upregulated in a pneumonia model. The contribution of BCAA biosynthesis to S. aureus growth in vivo remains to be determined, although biosynthesis likely plays a role in maintaining BCAA levels, as the biosynthetic genes are upregulated when S. aureus is grown in blood, the lung environment, and in nasal secretions. In S. pneumoniae, BCAA transport supports growth in a systemic infection model, pneumonia model, and meningitis model, but not in a colonization model, whereas BCAA biosynthesis is required for invasion of host tissue following intranasal colonization, but is not required for systemic infection. BCAA transport also contributes to growth of Yersinia pestis during systemic infection. Despite some pathogens being able to exploit extracellular BCAAs, some pathogens require BCAA biosynthesis for infection, including Klebsiella pneumoniae, Neisseria meningitidis, and P. aeruginosa.

Intracellular pathogens face the challenge of direct competition with the host for intracellular BCAAs since they are essential nutrients in humans. Indeed, several intracellular pathogens, including Burkholderia pseudomallei, Mycobacterium bovis, Mycobacterium tuberculosis, and L. monocytogenes rely on BCAA biosynthesis for replication inside host cells. Yet, some intracellular pathogens are auxotrophic for BCAAs and therefore necessitate transporters to obtain BCAAs. The BCAA auxotroph Legionella pneumophila requires the Val transporter PhtJ for intracellular growth, and pathogenic subspecies of Francisella, which have lost the capacity to synthesize BCAAs, require the Ile transporter IleP for intracellular replication and infection in vivo. Interestingly, F. tularensis has been observed to induce a transient increase in cytosolic BCAA concentrations following infection, suggesting that it might manipulate host metabolism to support its own growth during infection.

If deprived of BCAAs, Gram-positive pathogens face challenges not only in supporting protein synthesis and growth, but also in maintaining the appropriate BCFA content to protect against host defenses that target the bacterial membrane. A role for BCFA synthesis in promoting resistance to host defenses is best highlighted in L. monocytogenes, where BCFAs comprise 75 to 98% of the membrane. BCFA-deficient strains have increased susceptibility to antimicrobial peptide killing and lysozyme digestion and decreased production of the virulence factor listeriolysin O, all of which likely contribute to the decreased intracellular growth and virulence of a strain deficient of BCFAs. In S. aureus, BCFAs comprise 44 to 63% of the membrane and a BCFA-deficient strain exhibits reduced adherence to host cells and is attenuated in vivo.

While these studies reveal that BCAA deprivation limits pathogen metabolism and physiology in vivo, more research is needed to elucidate the relative importance of biosynthesis versus acquisition in various host niches and how this source preference might be regulated. One mechanism governing source preference involves positioning of the gene in the hierarchy of the CodY regulon. The BCAA biosynthetic operon and the transporter genes in B. subtilis are both controlled by CodY. CodY binds to a 15-nucleotide (nt) binding motif, AATTTTCWGAAAATT, and nucleotide substitutions in the motif that deviate from the consensus sequence decrease the binding affinity of CodY. The binding strength of the motif thus correlates with the extent of repression and dictates the positioning of the gene within the hierarchy of graded target gene derepression. In B. subtilis, BCAA biosynthesis and transport are derepressed at similar points along the spectrum of CodY activity, but in S. aureus, in which this hierarchical response is also observed, the BCAA transporter brnQ2 is derepressed upon modest decreases in CodY activity, whereas BCAA biosynthesis remains repressed at this same level of CodY inactivation, suggesting that S. aureus prioritizes nutrient scavenging upon modest nutrient depletion to prevent unnecessary divergence of carbon and nitrogen to nutrient synthesis. The positioning of other transcriptional regulators in the CodY hierarchy adds an additional layer of metabolic fine-tuning. For example, CodY is a direct repressor of braB, a BCAA transporter in B. subtilis, but it is a stronger repressor of scoC, which also represses braB expression. braB expression is therefore optimal at intermediate levels of CodY activity, when CodY-dependent braB repression is partially relieved, and scoC remains repressed. Such precise sensitivity to CodY activity represents one way by which pathogens can fine-tune the coordination of nutrient acquisition strategies.

BCAAs as host cues to regulate virulence.

The predominant role of CodY as a negative regulator of virulence and the hierarchical regulation of CodY target genes in S. aureus is but one example of how pathogens respond to BCAA starvation and adapt to their environment. In some pathogens, it has been shown that CodY can also function as a positive regulator. Table 2 outlines the positive and/or negative regulatory role of CodY on notable virulence factors in several Gram-positive pathogens. To fully appreciate the complexity of pathogen-specific CodY responses, this section will contrast the predominant repressive role of CodY in S. aureus to the complex role of CodY as both a positive and negative regulator of virulence in L. monocytogenes (summarized in Fig. 3). The advancements made in these pathogens reveal that pathogen lifestyle might have influenced the regulatory response coordinated in response to BCAA availability.

In S. aureus, CodY binds to DNA under BCAA-replete conditions and primarily acts as a repressor of virulence genes. CodY regulates approximately 5% of the S. aureus genome, with the majority of its targets (85%) subject to repression by CodY. These targets include virulence genes, such as the capsule genes, α-hemolysin and adhesion protein genes, as well as regulators of virulence gene expression, including the agr locus and saeRS two-component system. Most of the virulence genes are directly repressed by CodY, whereas others, including the capsule genes and hemolysin genes, are indirectly activated through agr. The genes activated by CodY, which fall into the categories of nucleotide transport/metabolism and adhesion proteins, do not have a CodY binding sequence, suggesting an indirect mechanism of regulation. The coordination of virulence gene expression with the environment is crucial for S. aureus to limit unwanted host damage, as exemplified by the hypervirulence of a codY mutant in a skin abscess and pneumonia model of infection. To ensure the appropriate expression of virulence genes, the CodY regulon is expressed as a hierarchy that depends on the extent of CodY activation and therefore nutrient (e.g., Ile) availability (Fig. 3). The graded response prioritizes expression of amino acid and peptide transport over synthesis upon modest nutrient limitation and reserves expression of hydrolytic enzyme and toxin production for more severe nutrient limitation (Fig. 3). Also within this spectrum are other virulence gene regulators, including the agr and sae loci, which together form a regulatory cascade that integrates several environmental cues, such as growth phase and host defenses. Together, the graded response and regulatory cascade are thought to maximize nutrient acquisition while limiting host toxicity.

In contrast to S. aureus, CodY in L. monocytogenes can bind to DNA under both BCAA-replete and BCAA-depleted conditions and can function as both a repressor and activator. CodY directly or indirectly regulates approximately 14% of L. monocytogenes genes. Approximately 66% of these genes are upregulated in a codY mutant compared to the wild-type strain when grown in nutrient-rich medium (i.e., BCAA replete), consistent with the role of CodY as a repressor (Fig. 3). The repressed genes are primarily involved in nutrient metabolism and transport and stress responses and include some virulence factors. The remaining 33% of differentially regulated genes that are downregulated in a codY mutant revealed an underappreciated role for CodY as an activator in this organism. The genes that are activated by CodY under these conditions include the arginine biosynthesis pathway and flagellar biosynthesis genes. Interestingly, CodY also acts as an activator under BCAA-depleted conditions, with approximately 30% of differentially regulated genes downregulated in a codY mutant compared to the wild-type strain when grown in BCAA-limited growth medium (Fig. 3). Under BCAA-depleted conditions, CodY is a direct activator of prfA, a global virulence gene regulator in L. monocytogenes. This leads to activation of PrfA-regulated virulence factors, including listeriolysin O and the surface protein ActA, which are important for intracellular replication and cell-to-cell spread, respectively. Consequently, an L. monocytogenes codY mutant is impaired in motility and intracellular replication. The role of CodY during L. monocytogenes infection is more difficult to discern, because although a codY mutant is attenuated in vivo in comparison to a wild-type (WT) strain, implicating CodY as an activator of virulence, a codY mutation rescues the virulence of a strain where CodY is constitutively active (i.e., a relA mutant), also demonstrating its role as a repressor of virulence. It is therefore challenging to classify CodY as either a repressor or activator of virulence in this organism. Rather its overall impact on virulence will depend on the resulting gene expression profile at any given CodY activation state.

The advancements made in these pathogens highlight how BCAA (namely, Ile) limitation is linked to promoting virulence of both organisms but via distinct mechanisms: that is, via CodY-dependent repression of virulence genes in S. aureus and CodY-dependent activation and/or repression of virulence genes in L. monocytogenes. As such, virulence is significantly influenced by CodY activity, such that two distinct lifestyles (i.e., nontoxic versus toxic for S. aureus and motile versus cytosolic replication for L. monocytogenes) are displayed at either end of the spectrum of BCAA concentrations, suggesting that even modest changes in intracellular Ile concentrations can have drastic consequences for virulence. It is not surprising, then, that two recent studies have uncovered that both pathogens tightly regulate BCAA biosynthesis via a shared mechanism resulting in a BCAA “auxotrophy” phenotype, which might allow them to increase their capacity to respond to a wider range of BCAA levels to reduce the likelihood of untimely virulence determinant expression.

BCAA auxotrophy: a metabolic strategy to promote environmental adaptation?

As discussed in a previous section, both S. aureus and L. monocytogenes require the addition of BCAAs to the growth medium to support growth due to minimal levels of BCAA biosynthesis. Two mechanisms of repression control this: (i) Ile-dependent CodY repression and (ii) a cis-acting BCAA-dependent attenuator. CodY represses the attenuator and the ilv-leu operon under high-Ile conditions to limit BCAA biosynthesis. As Ile is depleted, repression is relieved; however, the attenuator further regulates the levels of ilv-leu transcripts in response to Leu and Ile availability in S. aureus and all three BCAAs in L. monocytogenes. This additional “checkpoint” in repression is thought to delay the repletion of BCAAs, extending the range of BCAA starvation and therefore the range of CodY activation states. Indeed, an L. monocytogenes strain lacking the attenuator-dependent repression synthesizes more BCAAs and exhibits reduced expression of the virulence gene regulator prfA in comparison to the wild-type strain; that is to say, prompt repletion of BCAAs via endogenous synthesis prevents the cells from reaching a state of BCAA deprivation necessary for CodY to bind to the prfA promoter and activate its transcription. As discussed previously, several Gram-positive bacteria display little to no BCAA biosynthesis, suggesting that this might represent a metabolic strategy to better coordinate virulence gene expression in response to nutritional cues in the environment.

CONCLUSIONS AND FUTURE DIRECTIONS

Recent advancements in the area of BCAA metabolism have identified the importance of BCAA acquisition and synthesis for pathogen growth in vivo and have revealed that a pathogen’s preferred strategy reflects its unique physiological needs and host tissue preferences. An emerging theme is that regulation of nutrient source preference is critical to maintaining tight control over intracellular concentrations of BCAAs and ensures that pathogens are responsive to fluctuations in these levels and therefore are able to initiate the appropriate adaptive response, which can have significant consequences for virulence. Therefore, future studies should continue to focus on identifying how each of these mechanisms influences intracellular pools of BCAAs. In Gram-positive bacteria, this includes evaluating how manipulation of BCAA transporters and/or biosynthesis influences intracellular levels of Ile and, subsequently, CodY activity. In S. aureus, depletion of exogenous Ile has a significant impact on CodY activity, and therefore CodY target genes are derepressed in a strain lacking the Ile transporter BrnQ2. Similarly, mutation of BCAA transporters in B. subtilis leads to a decrease in CodY activation, although the sole contributions of each of the three transporters remain to be determined. Levels of endogenous synthesis, too, impact CodY activity in L. monocytogenes and B. subtilis. In Gram-negative bacteria, the role of BCAA deprivation in regulating virulence remains to be explored. Evidence in the Gram-negative swine pathogen Actinobacillus pleuropneumoniae suggests the existence of a parallel response. A. pleuropneumoniae encounters BCAA limitation in the porcine lung and requires BCAA biosynthesis for full virulence in this environment. Furthermore, BCAA deprivation triggers upregulation of not only BCAA biosynthesis, but also several genes that are upregulated during infection, some of which have putative Lrp binding sites. This suggests that BCAA deprivation, sensed via Lrp, might also act as an important environmental cue for Gram-negative pathogens. Future studies will provide more insight into how pathogens obtain BCAAs and how they regulate their intracellular levels to promote their survival and ability to cause disease.

References 168

  1. 1.

    Richardson AR, Somerville GA, Sonenshein AL 2015 Regulating the intersection of metabolism and pathogenesis in Gram-positive bacteria. Microbiol Spectr 3. doi:.

    Not in our library10.1128/microbiolspec.mbp-0004-2014

  2. 2.

    Görke B, Stülke J 2008 Carbon catabolite repression in bacteria: many ways to make the most out of nutrients. Nat Rev Microbiol 6:613–624. doi:.

    Not in our library10.1038/nrmicro1932

  3. 3.

    Brinsmade SR, Alexander EL, Livny J, Stettner AI, Segrè D, Rhee KY, Sonenshein AL 2014 Hierarchical expression of genes controlled by the Bacillus subtilis global regulatory protein CodY. Proc Natl Acad Sci U S A 111:8227–8232. doi:.

    Not in our library10.1073/pnas.1321308111

  4. 4.

    Belitsky BR, Sonenshein AL 2011 Contributions of multiple binding sites and effector-independent binding to CodY-mediated regulation in Bacillus subtilis. J Bacteriol 193:473–484. doi:.

    Not in our library10.1128/jb.01151-10

  5. 5.

    Waters NR, Samuels DJ, Behera RK, Livny J, Rhee KY, Sadykov MR, Brinsmade SR 2016 A spectrum of CodY activities drives metabolic reorganization and virulence gene expression in Staphylococcus aureus. Mol Microbiol 101:495–514. doi:.

    Not in our library10.1111/mmi.13404

  6. 6.

    Brinsmade SR 2016 CodY, a master integrator of metabolism and virulence in Gram-positive bacteria. Curr Genet 63:417–425. doi:.

    Not in our library10.1007/s00294-016-0656-5

  7. 7.

    Chou PY, Fasman GD 1973 Structural and functional role of leucine residues in proteins. J Mol Biol 74:263–281. doi:.

    Not in our library10.1016/0022-2836(73)90372-0

  8. 8.

    Lyu PC, Sherman JC, Chen A, Kallenbach NR 1991 Alpha-helix stabilization by natural and unnatural amino acids with alkyl side chains. Proc Natl Acad Sci U S A 88:5317–5320. doi:.

    Not in our library10.1073/pnas.88.12.5317

  9. 9.

    Betts M, Russell R 2003 Amino acid properties and consequences of substitutions, p 289–316. In Barnes MR, Gray IC (ed), Bioinformatics for geneticists. John Wiley & Sons, Hoboken, NJ.

    Not in our library

  10. 10.

    Webb ME, Smith AG, Abell C 2004 Biosynthesis of pantothenate. Nat Prod Rep 21:695–721. doi:.

    Not in our library10.1039/b316419p

  11. 11.

    Kaneda T 1991 Iso- and anteiso-fatty acids in bacteria: biosynthesis, function, and taxonomic significance. Microbiol Rev 55:288–302.

    Not in our library10.1128/mr.55.2.288-302.1991

  12. 12.

    Zhang YM, Rock CO 2008 Membrane lipid homeostasis in bacteria. Nat Rev Microbiol 6:222–233. doi:.

    Not in our library10.1038/nrmicro1839

  13. 13.

    Annous B, Becker L, Bayles D, Labeda D, Wilkinson B 1997 Critical role of anteiso-C15:0 fatty acid in the growth of Listeria monocytogenes at low temperatures. Appl Environ Microbiol 63:3887–3894.

    Not in our library10.1128/aem.63.10.3887-3894.1997

  14. 14.

    Chihib NE, Ribeiro da Silva M, Delattre G, Laroche M, Federighi M 2003 Different cellular fatty acid pattern behaviours of two strains of Listeria monocytogenes Scott A and CNL 895807 under different temperature and salinity conditions. FEMS Microbiol Lett 218:155–160. doi:.

    Not in our library10.1111/j.1574-6968.2003.tb11512.x

  15. 15.

    Giotis ES, McDowell DA, Blair IS, Wilkinson BJ 2007 Role of branched-chain fatty acids in pH stress tolerance in Listeria monocytogenes. Appl Environ Microbiol 73:997–1001. doi:.

    Not in our library10.1128/aem.00865-06

  16. 16.

    Jydegaard-Axelsen AM, Høiby PE, Holmstrøm K, Russell N, Knøchel S 2004 CO2- and anaerobiosis-induced changes in physiology and gene expression of different Listeria monocytogenes strains. Appl Environ Microbiol 70:4111–4117. doi:.

    Not in our library10.1128/aem.70.7.4111-4117.2004

  17. 17.

    Klein W, Weber MHW, Marahiel MA 1999 Cold shock response of Bacillus subtilis: isoleucine-dependent switch in the fatty acid branching pattern for membrane adaptation to low temperatures. J Bacteriol 181:5341–5349.

    Not in our library10.1128/jb.181.17.5341-5349.1999

  18. 18.

    Mastronicolis SK, Arvanitis N, Karaliota A, Litos C, Stavroulakis G, Moustaka H, Tsakirakis A, Heropoulos G 2005 Cold dependence of fatty acid profile of different lipid structures of Listeria monocytogenes. Food Microbiol 22:213–219. doi:.

    Not in our library10.1016/j.fm.2004.08.002

  19. 19.

    Jones CE, Shama G, Jones D, Roberts IS, Andrew PW 1997 Physiological and biochemical studies on psychrotolerance in Listeria monocytogenes. J Appl Microbiol 83:31–35. doi:.

    Not in our library10.1046/j.1365-2672.1997.d01-391.x

  20. 20.

    Nichols DS, Presser KA, Olley J, Ross T, McMeekin TA 2002 Variation of branched-chain fatty acids marks the normal physiological range for growth in Listeria monocytogenes. Appl Environ Microbiol 68:2809–2813. doi:.

    Not in our library10.1128/aem.68.6.2809-2813.2002

  21. 21.

    Zhu K, Bayles DO, Xiong A, Jayaswal RK, Wilkinson BJ 2005 Precursor and temperature modulation of fatty acid composition and growth of Listeria monocytogenes cold-sensitive mutants with transposon-interrupted branched-chain alpha-keto acid dehydrogenase. Microbiology 151:615–623. doi:.

    Not in our library10.1099/mic.0.27634-0

  22. 22.

    Zhu K, Ding X, Julotok M, Wilkinson BJ 2005 Exogenous isoleucine and fatty acid shortening ensure the high content of anteiso-C15:0 fatty acid required for low-temperature growth of Listeria monocytogenes. Appl Environ Microbiol 71:8002–8007. doi:.

    Not in our library10.1128/aem.71.12.8002-8007.2005

  23. 23.

    Tani TH, Khodursky A, Blumenthal RM, Brown PO, Matthews RG 2002 Adaptation to famine: a family of stationary-phase genes revealed by microarray analysis. Proc Natl Acad Sci U S A 99:13471–13476. doi:.

    Not in our library10.1073/pnas.212510999

  24. 24.

    Sonenshein AL 2005 CodY, a global regulator of stationary phase and virulence in Gram-positive bacteria. Curr Opin Microbiol 8:203–207. doi:.

    Not in our library10.1016/j.mib.2005.01.001

  25. 25.

    Gallant J, Irr J, Cashel M 1971 The mechanism of amino acid control of guanylate and adenylate biosynthesis. J Biol Chem 246:5812–5816.

    Not in our library

  26. 26.

    Calvo JM, Matthews RG 1994 The leucine-responsive regulatory protein, a global regulator of metabolism in Escherichia coli. Microbiol Rev 58:466–490.

    Not in our library10.1128/mr.58.3.466-490.1994

  27. 27.

    Ratnayake-Lecamwasam M, Serror P, Wong KW, Sonenshein AL 2001 Bacillus subtilis CodY represses early-stationary-phase genes by sensing GTP levels. Genes Dev 15:1093–1103. doi:.

    Not in our library10.1101/gad.874201

  28. 28.

    Guédon E, Serror P, Ehrlich SD, Renault P, Delorme C 2001 Pleiotropic transcriptional repressor CodY senses the intracellular pool of branched-chain amino acids in Lactococcus lactis. Mol Microbiol 40:1227–1239. doi:.

    Not in our library10.1046/j.1365-2958.2001.02470.x

  29. 29.

    Shivers RP, Sonenshein AL 2004 Activation of the Bacillus subtilis global regulator CodY by direct interaction with branched-chain amino acids. Mol Microbiol 53:599–611. doi:.

    Not in our library10.1111/j.1365-2958.2004.04135.x

  30. 30.

    Handke LD, Shivers RP, Sonenshein AL 2008 Interaction of Bacillus subtilis CodY with GTP. J Bacteriol 190:798–806. doi:.

    Not in our library10.1128/jb.01115-07

  31. 31.

    den Hengst CD, Curley P, Larsen R, Buist G, Nauta A, van Sinderen D, Kuipers OP, Kok J 2005 Probing direct interactions between CodY and the oppD promoter of Lactococcus lactis. J Bacteriol 187:512–521. doi:.

    Not in our library10.1128/jb.187.2.512-521.2005

  32. 32.

    Hendriksen WT, Bootsma HJ, Estevão S, Hoogenboezem T, De Jong A, De Groot R, Kuipers OP, Hermans PWM 2008 CodY of Streptococcus pneumoniae: link between nutritional gene regulation and colonization. J Bacteriol 190:590–601. doi:.

    Not in our library10.1128/jb.00917-07

  33. 33.

    Petranovic D, Guédon E, Sperandio B, Delorme C, Ehrlich D, Renault P 2004 Intracellular effectors regulating the activity of the Lactococcus lactis CodY pleiotropic transcription regulator. Mol Microbiol 53:613–621. doi:.

    Not in our library10.1111/j.1365-2958.2004.04136.x

  34. 34.

    Shivers RP, Dineen SS, Sonenshein AL 2006 Positive regulation of Bacillus subtilis ackA by CodY and CcpA: establishing a potential hierarchy in carbon flow. Mol Microbiol 62:811–822. doi:.

    Not in our library10.1111/j.1365-2958.2006.05410.x

  35. 35.

    Lobel L, Sigal N, Borovok I, Belitsky BR, Sonenshein AL, Herskovits AA 2015 The metabolic regulator CodY links Listeria monocytogenes metabolism to virulence by directly activating the virulence regulatory gene prfA. Mol Microbiol 95:624–644. doi:.

    Not in our library10.1111/mmi.12890

  36. 36.

    Molle V, Nakaura Y, Shivers RP, Yamaguchi H, Losick R, Fujita Y, Sonenshein AL 2003 Additional targets of the Bacillus subtilis global regulator CodY identified by chromatin immunoprecipitation and genome-wide transcript analysis. J Bacteriol 185:1911–1922. doi:.

    Not in our library10.1128/jb.185.6.1911-1922.2003

  37. 37.

    Majerczyk CD, Dunman PM, Luong TT, Lee CY, Sadykov MR, Somerville GA, Bodi K, Sonenshein AL 2010 Direct targets of CodY in Staphylococcus aureus. J Bacteriol 192:2861–2877. doi:.

    Not in our library10.1128/jb.00220-10

  38. 38.

    Pohl K, Francois P, Stenz L, Schlink F, Geiger T, Herbert S, Goerke C, Schrenzel J, Wolz C 2009 CodY in Staphylococcus aureus: a regulatory link between metabolism and virulence gene expression. J Bacteriol 191:2953–2963. doi:.

    Not in our library10.1128/jb.01492-08

  39. 39.

    Lobel L, Herskovits AA 2016 Systems level analyses reveal multiple regulatory activities of CodY controlling metabolism, motility and virulence in Listeria monocytogenes. PLoS Genet 12:e1005870. doi:.

    Not in our library10.1371/journal.pgen.1005870

  40. 40.

    Nawrocki KL, Edwards AN, Daou N, Bouillaut L, McBride SM 2016 CodY-dependent regulation of sporulation in Clostridium difficile. J Bacteriol 198:2113–2130. doi:.

    Not in our library10.1128/jb.00220-16

  41. 41.
    CodY Is a Global Regulator of Virulence-Associated Properties for <named-content content-type="genus-species">Clostridium perfringens</named-content> Type D Strain CN3718 · 2013
    Not checked
  42. 42.

    Qi M, Mei F, Wang H, Sun M, Wang G, Yu Z, Je Y, Li M 2015 Function of global regulator CodY in Bacillus thuringiensis BMB171 by comparative proteomic analysis. J Microbiol Biotechnol 25:152–161. doi:.

    Not in our library10.4014/jmb.1406.06036

  43. 43.

    Hsueh YH, Somers EB, Wong ACL 2008 Characterization of the codY gene and its influence on biofilm formation in Bacillus cereus. Arch Microbiol 189:557–568. doi:.

    Not in our library10.1007/s00203-008-0348-8

  44. 44.

    Lemos JA, Nascimento MM, Lin VK, Abranches J, Burne RA 2008 Global regulation by (p)ppGpp and CodY in Streptococcus mutans. J Bacteriol 190:5291–5299. doi:.

    Not in our library10.1128/jb.00288-08

  45. 45.

    McDowell EJ, Callegari EA, Malke H, Chaussee MS 2012 CodY-mediated regulation of Streptococcus pyogenes exoproteins. BMC Microbiol 12:114. doi:.

    Not in our library10.1186/1471-2180-12-114

  46. 46.

    van Schaik W, Château A, Dillies MA, Coppée JY, Sonenshein AL, Fouet A 2009 The global regulator CodY regulates toxin gene expression in Bacillus anthracis and is required for full virulence. Infect Immun 77:4437–4445. doi:.

    Not in our library10.1128/iai.00716-09

  47. 47.

    Château A, van Schaik W, Six A, Aucher W, Fouet A 2011 CodY regulation is required for full virulence and heme iron acquisition in Bacillus anthracis. FASEB J 25:4445–4456. doi:.

    Not in our library10.1096/fj.11-188912

  48. 48.

    Château A, van Schaik W, Joseph P, Handke LD, McBride SM, Smeets FMH, Sonenshein AL, Fouet A 2013 Identification of CodY targets in Bacillus anthracis by genome-wide in vitro binding analysis. J Bacteriol 195:1204–1213. doi:.

    Not in our library10.1128/jb.02041-12

  49. 49.

    Böhm ME, Krey VM, Jeßberger N, Frenzel E, Scherer S 2016 Comparative bioinformatics and experimental analysis of the intergenic regulatory regions of Bacillus cereus hbl and nhe enterotoxin operons and the impact of CodY on virulence heterogeneity. Front Microbiol 7:768. doi:.

    Not in our library10.3389/fmicb.2016.00768

  50. 50.

    Frenzel E, Doll V, Pauthner M, Lücking G, Scherer S, Ehling-Schulz M 2012 CodY orchestrates the expression of virulence determinants in emetic Bacillus cereus by impacting key regulatory circuits. Mol Microbiol 85:67–88. doi:.

    Not in our library10.1111/j.1365-2958.2012.08090.x

  51. 51.

    Lindbäck T, Mols M, Basset C, Granum PE, Kuipers OP, Kovács ÁT 2012 CodY, a pleiotropic regulator, influences multicellular behaviour and efficient production of virulence factors in Bacillus cereus. Environ Microbiol 14:2233–2246. doi:.

    Not in our library10.1111/j.1462-2920.2012.02766.x

  52. 52.

    Dineen SS, McBride SM, Sonenshein AL 2010 Integration of metabolism and virulence by Clostridium difficile CodY. J Bacteriol 192:5350–5362. doi:.

    Not in our library10.1128/jb.00341-10

  53. 53.

    Dineen SS, Villapakkam AC, Nordman JT, Sonenshein AL 2007 Repression of Clostridium difficile toxin gene expression by CodY. Mol Microbiol 66:206–219. doi:.

    Not in our library10.1111/j.1365-2958.2007.05906.x

  54. 54.

    Li J, Freedman JC, McClane BA 2015 NanI sialidase, CcpA, and CodY work together to regulate epsilon toxin production by Clostridium perfringens type D strain CN3718. J Bacteriol 197:3339–3353. doi:.

    Not in our library10.1128/jb.00349-15

  55. 55.

    Li J, Freedman JC, Evans DR, McClane BA 2017 CodY promotes sporulation and enterotoxin production by Clostridium perfringens type A strain S101. Infect Immun 85:e00855-16. doi:.

    Not in our library10.1128/iai.00855-16

  56. 56.

    Bennett HJ, Pearce DM, Glenn S, Taylor CM, Kuhn M, Sonenshein AL, Andrew PW, Roberts IS 2007 Characterization of relA and codY mutants of Listeria monocytogenes: identification of the CodY regulon and its role in virulence. Mol Microbiol 63:1453–1467. doi:.

    Not in our library10.1111/j.1365-2958.2007.05597.x

  57. 57.

    Lobel L, Sigal N, Borovok I, Ruppin E, Herskovits AA 2012 Integrative genomic analysis identifies isoleucine and CodY as regulators of Listeria monocytogenes virulence. PLoS Genet 8:e1002887. doi:.

    Not in our library10.1371/journal.pgen.1002887

  58. 58.

    Rivera FE, Miller HK, Kolar SL, Stevens SM, Shaw LN 2012 The impact of CodY on virulence determinant production in community-associated methicillin-resistant Staphylococcus aureus. Proteomics 12:263–268. doi:.

    Not in our library10.1002/pmic.201100298

  59. 59.

    Montgomery CP, Boyle-Vavra S, Roux A, Ebine K, Sonenshein AL, Daum RS 2012 CodY deletion enhances in vivo virulence of community-associated methicillin-resistant Staphylococcus aureus clone USA300. Infect Immun 80:2382–2389. doi:.

    Not in our library10.1128/iai.06172-11

  60. 60.

    Majerczyk CD, Sadykov MR, Luong TT, Lee C, Somerville GA, Sonenshein AL 2008 Staphylococcus aureus CodY negatively regulates virulence gene expression. J Bacteriol 190:2257–2265. doi:.

    Not in our library10.1128/jb.01545-07

  61. 61.

    Malke H, Ferretti JJ 2007 CodY-affected transcriptional gene expression of Streptococcus pyogenes during growth in human blood. J Med Microbiol 56:707–714. doi:.

    Not in our library10.1099/jmm.0.46984-0

  62. 62.

    Malke H, Steiner K, McShan WM, Ferretti JJ 2006 Linking the nutritional status of Streptococcus pyogenes to alteration of transcriptional gene expression: the action of CodY and RelA. Int J Med Microbiol 296:259–275. doi:.

    Not in our library10.1016/j.ijmm.2005.11.008

  63. 63.

    Kreth J, Chen Z, Ferretti J, Malke H 2011 Counteractive balancing of transcriptome expression involving CodY and CovRS in Streptococcus pyogenes. J Bacteriol 193:4153–4165. doi:.

    Not in our library10.1128/jb.00061-11

  64. 64.

    Stenz L, Francois P, Whiteson K, Wolz C, Linder P, Schrenzel J 2011 The CodY pleiotropic repressor controls virulence in Gram-positive pathogens. FEMS Immunol Med Microbiol 62:123–139. doi:.

    Not in our library10.1111/j.1574-695x.2011.00812.x

  65. 65.

    Somerville GA, Proctor RA 2009 At the crossroads of bacterial metabolism and virulence factor synthesis in staphylococci. Microbiol Mol Biol Rev 73:233–248. doi:.

    Not in our library10.1128/mmbr.00005-09

  66. 66.

    Landgraf JR, Wu J, Calvo JM 1996 Effects of nutrition and growth rate on Lrp levels in Escherichia coli. J Bacteriol 178:6930–6936. doi:.

    Not in our library10.1128/jb.178.23.6930-6936.1996

  67. 67.

    Hauryliuk V, Atkinson GC, Murakami KS, Tenson T, Gerdes K 2015 Recent functional insights into the role of (p)ppGpp in bacterial physiology. Nat Rev Microbiol 13:298–309. doi:.

    Not in our library10.1038/nrmicro3448

  68. 68.

    Fang M, Bauer CE 2018 Regulation of stringent factor by branched-chain amino acids. Proc Natl Acad Sci U S A 115:6446–6451. doi:.

    Not in our library10.1073/pnas.1803220115

  69. 69.

    Kaiser JC, King AN, Grigg JC, Sheldon JR, Edgell DR, Murphy MEP, Brinsmade SR, Heinrichs DE 2018 Repression of branched-chain amino acid synthesis in Staphylococcus aureus is mediated by isoleucine via CodY, and by a leucine-rich attenuator peptide. PLoS Genet 14:e1007159. doi:.

    Not in our library10.1371/journal.pgen.1007159

  70. 70.

    Villapakkam AC, Handke LD, Belitsky BR, Levdikov VM, Wilkinson AJ, Sonenshein AL 2009 Genetic and biochemical analysis of the interaction of Bacillus subtilis CodY with branched-chain amino acids. J Bacteriol 191:6865–6876. doi:.

    Not in our library10.1128/jb.00818-09

  71. 71.

    Guédon E, Sperandio B, Pons N, Ehrlich SD, Renault P 2005 Overall control of nitrogen metabolism in Lactococcus lactis by CodY, and possible models for CodY regulation in Firmicutes. Microbiology 151:3895–3909. doi:.

    Not in our library10.1099/mic.0.28186-0

  72. 72.

    Santiago B, Marek M, Faustoferri RC, Quivey RG 2013 The Streptococcus mutans aminotransferase encoded by ilvE is regulated by CodY and CcpA. J Bacteriol 195:3552–3562. doi:.

    Not in our library10.1128/jb.00394-13

  73. 73.

    Kim JN, Burne RA 2017 CcpA and CodY coordinate acetate metabolism in Streptococcus mutans. Appl Environ Microbiol 83:e03274-16. doi:.

    Not in our library10.1128/aem.03274-16

  74. 74.

    Lemos JA, Lin VK, Nascimento MM, Abranches J, Burne RA 2007 Three gene products govern (p)ppGpp production by Streptococcus mutans. Mol Microbiol 65:1568–1581. doi:.

    Not in our library10.1111/j.1365-2958.2007.05897.x

  75. 75.

    Wray LV, Fisher SH 2011 Bacillus subtilis CodY operators contain overlapping CodY binding sites. J Bacteriol 193:4841–4848. doi:.

    Not in our library10.1128/jb.05258-11

  76. 76.

    Brenner M, Lobel L, Borovok I, Sigal N, Herskovits AA 2018 Controlled branched-chain amino acids auxotrophy in Listeria monocytogenes allows isoleucine to serve as a host signal and virulence effector. PLoS Genet 14:e1007283. doi:.

    Not in our library10.1371/journal.pgen.1007283

  77. 77.

    Amorim Franco TM, Blanchard JS 2017 Bacterial branched-chain amino acid biosynthesis: structures, mechanisms, and drugability. Biochemistry 56:5849–5865. doi:.

    Not in our library10.1021/acs.biochem.7b00849

  78. 78.

    Lawther RP, Wek RC, Lopes JM, Pereira R, Taillon BE, Hatfield GW 1987 The complete nucleotide sequence of the ilvGMEDA operon of Escherichia coli K-12. Nucleic Acids Res 15:2137–2155. doi:.

    Not in our library10.1093/nar/15.5.2137

  79. 79.

    Nargang FE, Subrahmanyam CS, Umbarger HE 1980 Nucleotide sequence of ilvGEDA operon attenuator region of Escherichia coli. Proc Natl Acad Sci U S A 77:1823–1827. doi:.

    Not in our library10.1073/pnas.77.4.1823

  80. 80.

    Friden P, Newman T, Freundlich M 1982 Nucleotide sequence of the ilvB promoter-regulatory region: a biosynthetic operon controlled by attenuation and cyclic AMP. Proc Natl Acad Sci U S A 79:6156–6160. doi:.

    Not in our library10.1073/pnas.79.20.6156

  81. 81.

    Wessler SR, Calvo JM 1981 Control of leu operon expression in Escherichia coli by a transcription attenuation mechanism. J Mol Biol 149:579–597. doi:.

    Not in our library10.1016/0022-2836(81)90348-x

  82. 82.

    Gemmill RM, Wessler SR, Keller EB, Calvo JM 1979 Leu operon of Salmonella typhimurium is controlled by an attenuation mechanism. Proc Natl Acad Sci U S A 76:4941–4945. doi:.

    Not in our library10.1073/pnas.76.10.4941

  83. 83.

    Searles LL, Wessler SR, Calvo JM 1983 Transcription attenuation is the major mechanism by which the leu operon of Salmonella typhimurium is controlled. J Mol Biol 163:377–394. doi:.

    Not in our library10.1016/0022-2836(83)90064-5

  84. 84.

    Vitreschak AG, Lyubetskaya EV, Shirshin MA, Gelfand MS, Lyubetsky VA 2004 Attenuation regulation of amino acid biosynthetic operons in proteobacteria: comparative genomics analysis. FEMS Microbiol Lett 234:357–370. doi:.

    Not in our library10.1016/j.femsle.2004.04.005

  85. 85.

    Platko JV, Willins DA, Calvo JM 1990 The ilvIH operon of Escherichia coli is positively regulated. J Bacteriol 172:4563–4570. doi:.

    Not in our library10.1128/jb.172.8.4563-4570.1990

  86. 86.

    Ricca E, Aker DA, Calvo JM 1989 A protein that binds to the regulatory region of the Escherichia coli ilvIH operon. J Bacteriol 171:1658–1664. doi:.

    Not in our library10.1128/jb.171.3.1658-1664.1989

  87. 87.

    Rhee KY, Parekh BS, Hatfield GW 1996 Leucine-responsive regulatory protein-DNA interactions in the leader region of the ilvGMEDA operon of Escherichia coli. J Biol Chem 271:26499–26507. doi:.

    Not in our library10.1074/jbc.271.43.26499

  88. 88.

    Shivers RP, Sonenshein AL 2005 Bacillus subtilis ilvB operon: an intersection of global regulons. Mol Microbiol 56:1549–1559. doi:.

    Not in our library10.1111/j.1365-2958.2005.04634.x

  89. 89.

    Tojo S, Satomura T, Morisaki K, Deutscher J, Hirooka K, Fujita Y 2005 Elaborate transcription regulation of the Bacillus subtilis ilv-leu operon involved in the biosynthesis of branched-chain amino acids through global regulators of CcpA, CodY and TnrA. Mol Microbiol 56:1560–1573. doi:.

    Not in our library10.1111/j.1365-2958.2005.04635.x

  90. 90.

    Henkin TM 1996 The role of CcpA transcriptional regulator in carbon metabolism in Bacillus subtilis. FEMS Microbiol Lett 135:9–15. doi:.

    Not in our library10.1111/j.1574-6968.1996.tb07959.x

  91. 91.

    Fujita Y, Satomura T, Tojo S, Hirooka K 2014 CcpA-mediated catabolite activation of the Bacillus subtilis ilv-leu operon and its negation by either CodY- or TnrA-mediated negative regulation. J Bacteriol 196:3793–3806. doi:.

    Not in our library10.1128/jb.02055-14

  92. 92.

    Grandoni JA, Zahler SA, Calvo JM 1992 Transcriptional regulation of the ilv-leu operon of Bacillus subtilis. J Bacteriol 174:3212–3219. doi:.

    Not in our library10.1128/jb.174.10.3212-3219.1992

  93. 93.

    Grandoni JA, Fulmer SB, Brizzio V, Zahler SA, Calvo JM 1993 Regions of the Bacillus subtilis ilv-leu operon involved in regulation by leucine. J Bacteriol 175:7581–7593. doi:.

    Not in our library10.1128/jb.175.23.7581-7593.1993

  94. 94.

    Marta PT, Ladner RD, Grandoni JA 1996 A CUC triplet confers leucine-dependent regulation of the Bacillus subtilis ilv-leu operon. J Bacteriol 178:2150–2153. doi:.

    Not in our library10.1128/jb.178.7.2150-2153.1996

  95. 95.

    Mäder U, Hennig S, Hecker M, Homuth G 2004 Transcriptional organization and posttranscriptional regulation of the Bacillus subtilis branched-chain amino acid biosynthesis genes. J Bacteriol 186:2240–2252. doi:.

    Not in our library10.1128/jb.186.8.2240-2252.2004

  96. 96.

    Kormelink TG, Koenders E, Hagemeijer Y, Overmars L, Siezen RJ, de Vos WM, Francke C 2012 Comparative genome analysis of central nitrogen metabolism and its control by GlnR in the class Bacilli. BMC Genomics 13:191. doi:.

    Not in our library10.1186/1471-2164-13-191

  97. 97.

    Godon JJ, Chopin MC, Ehrlich SD 1992 Branched-chain amino acid biosynthesis genes in Lactococcus lactis subsp. lactis. J Bacteriol 174:6580–6589. doi:.

    Not in our library10.1128/jb.174.20.6580-6589.1992

  98. 98.

    Keilhauer C, Eggeling L, Sahm H 1993 Isoleucine synthesis in Corynebacterium glutamicum: molecular analysis of the ilvB-ilvN-ilvC operon. J Bacteriol 175:5595–5603. doi:.

    Not in our library10.1128/jb.175.17.5595-5603.1993

  99. 99.

    Pátek M, Krumbach K, Eggeling L, Sahm H 1994 Leucine synthesis in Corynebacterium glutamicum: enzyme activities, structure of leuA, and effect of leuA inactivation on lysine synthesis. Appl Environ Microbiol 60:133–140.

    Not in our library10.1128/aem.60.1.133-140.1994

  100. 100.

    Millman A, Dar D, Shamir M, Sorek R 2017 Computational prediction of regulatory, premature transcription termination in bacteria. Nucleic Acids Res 45:886–893. doi:.

    Not in our library10.1093/nar/gkw749

  101. 101.

    Lei T, Yang J, Zheng L, Markowski T, Witthuhn BA, Ji Y 2012 The essentiality of staphylococcal Gcp is independent of its repression of branched-chain amino acids biosynthesis. PLoS One 7:e46836. doi:.

    Not in our library10.1371/journal.pone.0046836

  102. 102.

    Lei T, Yang J, Ji Y 2015 Determination of essentiality and regulatory function of staphylococcal YeaZ in branched-chain amino acid biosynthesis. Virulence 6:75–84. doi:.

    Not in our library10.4161/21505594.2014.986415

  103. 103.

    Eisenreich W, Slaghuis J, Laupitz R, Bussemer J, Stritzker J, Schwarz C, Schwarz R, Dandekar T, Goebel W, Bacher A 2006 13C isotopologue perturbation studies of Listeria monocytogenes carbon metabolism and its modulation by the virulence regulator PrfA. Proc Natl Acad Sci U S A 103:2040–2045. doi:.

    Not in our library10.1073/pnas.0507580103

  104. 104.

    Joseph B, Goebel W 2007 Life of Listeria monocytogenes in the host cells’ cytosol. Microbes Infect 9:1188–1195. doi:.

    Not in our library10.1016/j.micinf.2007.05.006

  105. 105.

    Härtel T, Eylert E, Schulz C, Petruschka L, Gierok P, Grubmüller S, Lalk M, Eisenreich W, Hammerschmidt S 2012 Characterization of central carbon metabolism of Streptococcus pneumoniae by isotopologue profiling. J Biol Chem 287:4260–4274. doi:.

    Not in our library10.1074/jbc.m111.304311

  106. 106.

    Willenborg J, Huber C, Koczula A, Lange B, Eisenreich W, Valentin-Weigand P, Goethe R 2015 Characterization of the pivotal carbon metabolism of Streptococcus suis serotype 2 under ex vivo and chemically defined in vitro conditions by isotopologue profiling. J Biol Chem 290:5840–5854. doi:.

    Not in our library10.1074/jbc.m114.619163

  107. 107.

    Kaiser JC, Sen S, Sinha A, Wilkinson BJ, Heinrichs DE 2016 The role of two branched-chain amino acid transporters in Staphylococcus aureus growth, membrane fatty acid composition and virulence. Mol Microbiol 102:850–864. doi:.

    Not in our library10.1111/mmi.13495

  108. 108.

    Adams MD, Wagner LM, Graddis TJ, Landick R, Antonucci TK, Gibson AL, Oxender DL 1990 Nucleotide sequence and genetic characterization reveal six essential genes for the LIV-I and LS transport systems of Escherichia coli. J Biol Chem 265:11436–11443.

    Not in our library

  109. 109.

    Furlong CE, Weiner JH 1970 Purification of a leucine-specific binding protein from Escherichia coli. Biochem Biophys Res Commun 38:1076–1083. doi:.

    Not in our library10.1016/0006-291x(70)90349-9

  110. 110.

    Penrose W, Nichoalds G, Piperno JR, Oxender DL 1968 Purification and properties of a leucine-binding protein from Escherichia coli. J Biol Chem 243:5921–5928.

    Not in our library

  111. 111.

    Matsubara K, Ohnishi K, Kiritani K 1988 The third general transport system for branched-chain amino acids in Salmonella typhimurium. J Gen Appl Microbiol 34:183–189. doi:.

    Not in our library10.2323/jgam.34.183

  112. 112.

    Hoshino T, Kose-terai K, Uratani Y 1991 Isolation of the braZ gene encoding the carrier for a novel branched-chain amino acid transport system in Pseudomonas aeruginosa PAO. J Bacteriol 173:1855–1861. doi:.

    Not in our library10.1128/jb.173.6.1855-1861.1991

  113. 113.

    Wood JM 1975 Leucine transport in Escherichia coli. The resolution of multiple transport systems and their coupling to metabolic energy. J Biol Chem 250:4477–4485.

    Not in our library

  114. 114.

    Gesbert G, Ramond E, Tros F, Dairou J, Frapy E, Barel M, Charbit A 2015 Importance of branched-chain amino acid utilization in Francisella intracellular adaptation. Infect Immun 83:173–183. doi:.

    Not in our library10.1128/iai.02579-14

  115. 115.

    Chen DE, Podell S, Sauer JD, Swanson MS, Saier MH 2008 The phagosomal nutrient transporter (Pht) family. Microbiology 154:42–53. doi:.

    Not in our library10.1099/mic.0.2007/010611-0

  116. 116.

    den Hengst CD, Groeneveld M, Kuipers OP, Kok J 2006 Identification and functional characterization of the Lactococcus lactis CodY-regulated branched-chain amino acid permease BcaP (CtrA). J Bacteriol 188:3280–3289. doi:.

    Not in our library10.1128/jb.188.9.3280-3289.2006

  117. 117.

    Trip H, Mulder NL, Lolkema JS 2013 Cloning, expression, and functional characterization of secondary amino acid transporters of Lactococcus lactis. J Bacteriol 195:340–350. doi:.

    Not in our library10.1128/jb.01948-12

  118. 118.

    Belitsky BR 2015 Role of branched-chain amino acid transport in Bacillus subtilis CodY activity. J Bacteriol 197:1330–1338. doi:.

    Not in our library10.1128/jb.02563-14

  119. 119.

    Kaiser JC, Omer S, Sheldon JR, Welch I, Heinrichs DE 2015 Role of BrnQ1 and BrnQ2 in branched-chain amino acid transport and virulence in Staphylococcus aureus. Infect Immun 83:1019–1029. doi:.

    Not in our library10.1128/iai.02542-14

  120. 120.

    Basavanna S, Khandavilli S, Yuste J, Cohen JM, Hosie AHF, Webb AJ, Thomas GH, Brown JS 2009 Screening of Streptococcus pneumoniae ABC transporter mutants demonstrates that LivJHMGF, a branched-chain amino acid ABC transporter, is necessary for disease pathogenesis. Infect Immun 77:3412–3423. doi:.

    Not in our library10.1128/iai.01543-08

  121. 121.

    Stucky K, Hagting A, Klein JR, Matern H, Henrich B, Konings WN, Plapp R 1995 Cloning and characterization of brnQ, a gene encoding a low-affinity, branched-chain amino acid carrier in Lactobacillus delbrückii subsp. lactis DSM7290. Mol Gen Genet 249:682–690. doi:.

    Not in our library10.1007/bf00418038

  122. 122.

    Tauch A, Hermann T, Burkovski A, Krämer R, Pühler A, Kalinowski J 1998 Isoleucine uptake in Corynebacterium glutamicum ATCC 13032 is directed by the brnQ gene product. Arch Microbiol 169:303–312. doi:.

    Not in our library10.1007/s002030050576

  123. 123.

    Sun YH, Bakshi S, Chalmers R, Tang CM 2000 Functional genomics of Neisseria meningitidis pathogenesis. Nat Med 6:1269–1273. doi:.

    Not in our library10.1038/81380

  124. 124.

    Wang J, Mushegian A, Lory S, Jin S 1996 Large-scale isolation of candidate virulence genes of Pseudomonas aeruginosa by in vivo selection. Proc Natl Acad Sci U S A 93:10434–10439. doi:.

    Not in our library10.1073/pnas.93.19.10434

  125. 125.

    Coulter SN, Schwan WR, Ng EY, Langhorne MH, Ritchie HD, Westbrock-Wadman S, Hufnagle WO, Folger KR, Bayer AS, Stover CK 1998 Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol Microbiol 30:393–404.

    Not in our library10.1046/j.1365-2958.1998.01075.x

  126. 126.

    Fuller TE, Kennedy MJ, Lowery DE 2000 Identification of Pasteurella multocida virulence genes in a septicemic mouse model using signature-tagged mutagenesis. Microb Pathog 29:25–38. doi:.

    Not in our library10.1006/mpat.2000.0365

  127. 127.

    Benton BM, Zhang JP, Bond S, Pope C, Christian T, Lee L, Winterberg KM, Schmid MB, Buysse JM 2004 Large-scale identification of genes required for full virulence of Staphylococcus aureus. J Bacteriol 186:8478–8489. doi:.

    Not in our library10.1128/jb.186.24.8478-8489.2004

  128. 128.

    Palace SG, Proulx MK, Lu S, Baker RE, Goguen JD 2014 Genome-wide mutant fitness profiling identifies nutritional requirements for optimal growth of Yersinia pestis in deep tissue. mBio 5:e01385-14. doi:.

    Not in our library10.1128/mbio.01385-14

  129. 129.

    Molzen TE, Burghout P, Bootsma HJ, Brandt CT, van der Gaast-de Jongh CE, Eleveld MJ, Verbeek MM, Frimodt-Møller N, Østergaard C, Hermans PWM 2011 Genome-wide identification of Streptococcus pneumoniae genes essential for bacterial replication during experimental meningitis. Infect Immun 79:288–297. doi:.

    Not in our library10.1128/iai.00631-10

  130. 130.

    Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vázquez-Fresno R, Sajed T, Johnson D, Li C, Karu N, Sayeeda Z, Lo E, Assempour N, Berjanskii M, Singhal S, Arndt D, Liang Y, Badran H, Grant J, Serra-Cayuela A, Liu Y, Mandal R, Neveu V, Pon A, Knox C, Wilson M, Manach C, Scalbert A 2018 HMDB 4.0: the Human Metabolome Database for 2018. Nucleic Acids Res 46:D608–D617. doi:.

    Not in our library10.1093/nar/gkx1089

  131. 131.
    Nutrient Limitation Governs Staphylococcus aureus Metabolism and Niche Adaptation in the Human Nose · 2014
    No notice
  132. 132.

    Chaffin DO, Taylor D, Skerrett SJ, Rubens CE 2012 Changes in the Staphylococcus aureus transcriptome during early adaptation to the lung. PLoS One 7:e41329. doi:.

    Not in our library10.1371/journal.pone.0041329

  133. 133.
    Global Changes in Staphylococcus aureus Gene Expression in Human Blood · 2011
    No notice
  134. 134.

    Kim GL, Lee S, Luong TT, Nguyen CT, Park SS, Pyo S, Rhee DK 2017 Effect of decreased BCAA synthesis through disruption of ilvC gene on the virulence of Streptococcus pneumoniae. Arch Pharm Res 40:921–932. doi:.

    Not in our library10.1007/s12272-017-0931-0

  135. 135.
    Genome-Wide Identification of <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Fitness Genes during Lung Infection · 2015
    Not checked
  136. 136.

    Atkins T, Prior RG, Mack K, Russell P, Nelson M, Oyston PCF, Dougan G, Titball RW 2002 A mutant of Burkholderia pseudomallei, auxotrophic in the branched-chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect Immun 70:5290–5294. doi:.

    Not in our library10.1128/iai.70.9.5290-5294.2002

  137. 137.

    McAdam RA, Weisbrod TR, Martin J, Scuderi JD, Brown AM, Cirillo JD, Bloom BR, Jacobs WR 1995 In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect Immun 63:1004–1012.

    Not in our library10.1128/iai.63.3.1004-1012.1995

  138. 138.

    Bange FC, Brown AM, Jacobs WR 1996 Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages. Infect Immun 64:1794–1799.

    Not in our library10.1128/iai.64.5.1794-1799.1996

  139. 139.

    Awasthy D, Gaonkar S, Shandil RK, Yadav R, Bharath S, Marcel N, Subbulakshmi V, Sharma U 2009 Inactivation of the ilvB1 gene in Mycobacterium tuberculosis leads to branched-chain amino acid auxotrophy and attenuation of virulence in mice. Microbiology 155:2978–2987. doi:.

    Not in our library10.1099/mic.0.029884-0

  140. 140.

    Joseph B, Przybilla K, Stühler C, Schauer K, Slaghuis J, Fuchs TM, Goebel W 2006 Identification of Listeria monocytogenes genes contributing to intracellular replication by expression profiling and mutant screening. J Bacteriol 188:556–568. doi:.

    Not in our library10.1128/jb.188.2.556-568.2006

  141. 141.

    Eisenreich W, Heuner K 2016 The life stage-specific pathometabolism of Legionella pneumophila. FEBS Lett 590:3868–3886. doi:.

    Not in our library10.1002/1873-3468.12326

  142. 142.

    Sen S, Sirobhushanam S, Hantak MP, Lawrence P, Brenna JT, Gatto C, Wilkinson BJ 2015 Short branched-chain C6 carboxylic acids result in increased growth, novel “unnatural” fatty acids and increased membrane fluidity in a Listeria monocytogenes branched-chain fatty acid-deficient mutant. Biochim Biophys Acta 1851:1406–1415. doi:.

    Not in our library10.1016/j.bbalip.2015.07.006

  143. 143.

    Sun Y, Wilkinson BJ, Standiford TJ, Akinbi HT, O’Riordan MXD 2012 Fatty acids regulate stress resistance and virulence factor production for Listeria monocytogenes. J Bacteriol 194:5274–5284. doi:.

    Not in our library10.1128/jb.00045-12

  144. 144.

    Sun Y, O’Riordan MXD 2010 Branched-chain fatty acids promote Listeria monocytogenes intracellular infection and virulence. Infect Immun 78:4667–4673. doi:.

    Not in our library10.1128/iai.00546-10

  145. 145.

    Singh VK, Hattangady DS, Giotis ES, Singh AK, Chamberlain NR, Stuart MK, Wilkinson BJ 2008 Insertional inactivation of branched-chain alpha-keto acid dehydrogenase in Staphylococcus aureus leads to decreased branched-chain membrane fatty acid content and increased susceptibility to certain stresses. Appl Environ Microbiol 74:5882–5890. doi:.

    Not in our library10.1128/aem.00882-08

  146. 146.

    Sen S, Sirobhushanam S, Johnson SR, Song Y, Tefft R, Gatto C, Wilkinson BJ 2016 Growth-environment dependent modulation of Staphylococcus aureus branched-chain to straight-chain fatty acid ratio and incorporation of unsaturated fatty acids. PLoS One 11:e0165300. doi:.

    Not in our library10.1371/journal.pone.0165300

  147. 147.

    Belitsky BR, Sonenshein AL 2008 Genetic and biochemical analysis of CodY-binding sites in Bacillus subtilis. J Bacteriol 190:1224–1236. doi:.

    Not in our library10.1128/jb.01780-07

  148. 148.

    Belitsky BR, Sonenshein AL 2013 Genome-wide identification of Bacillus subtilis CodY-binding sites at single-nucleotide resolution. Proc Natl Acad Sci U S A 110:7026–7031. doi:.

    Not in our library10.1073/pnas.1300428110

  149. 149.

    Belitsky BR, Brinsmade SR, Sonenshein AL 2015 Intermediate levels of Bacillus subtilis CodY activity are required for derepression of the branched-chain amino acid permease, BraB. PLoS Genet 11:e1005600. doi:.

    Not in our library10.1371/journal.pgen.1005600

  150. 150.

    Mlynek KD, Sause WE, Moormeier DE, Sadykov MR, Hill KR, Torres VJ, Bayles KW, Brinsmade SR 2018 Nutritional regulation of the Sae two-component system by CodY in Staphylococcus aureus. J Bacteriol 200:e00012-18. doi:.

    Not in our library10.1128/jb.00012-18

  151. 151.

    Geiger T, Goerke C, Mainiero M, Kraus D, Wolz C 2008 The virulence regulator Sae of Staphylococcus aureus: promoter activities and response to phagocytosis-related signals. J Bacteriol 190:3419–3428. doi:.

    Not in our library10.1128/jb.01927-07

  152. 152.

    Kocks C, Gouin E, Tabouret M, Berche P, Ohayon H, Cossart P 1992 Listeria monocytogenes-induced actin assembly requires the actA gene product, a surface protein. Cell 68:521–531. doi:.

    Not in our library10.1016/0092-8674(92)90188-i

  153. 153.

    Cossart P, Vicente MF, Mengaud J, Baquero F, Perez-Diaz JC, Berche P 1989 Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect Immun 57:3629–3636.

    Not in our library10.1128/iai.57.11.3629-3636.1989

  154. 154.

    Subashchandrabose S, LeVeque RM, Wagner TK, Kirkwood RN, Kiupel M, Mulks MH 2009 Branched-chain amino acids are required for the survival and virulence of Actinobacillus pleuropneumoniae in swine. Infect Immun 77:4925–4933. doi:.

    Not in our library10.1128/iai.00671-09

  155. 155.

    Wagner TK, Mulks MH 2006 A subset of Actinobacillus pleuropneumoniae in vivo induced promoters respond to branched-chain amino acid limitation. FEMS Immunol Med Microbiol 48:192–204. doi:.

    Not in our library10.1111/j.1574-695x.2006.00147.x

  156. 156.

    Braun PR, Al-Younes H, Gussmann J, Klein J, Schneider E, Meyer TF 2008 Competitive inhibition of amino acid uptake suppresses chlamydial growth: involvement of the chlamydial amino acid transporter BrnQ. J Bacteriol 190:1822–1830. doi:.

    Not in our library10.1128/jb.01240-07

  157. 157.

    Rahmanian M, Claus DR, Oxender DL 1973 Multiplicity of leucine transport systems in Escherichia coli K-12. J Bacteriol 116:1258–1266.

    Not in our library10.1128/jb.116.3.1258-1266.1973

  158. 158.

    Hoshino T, Kageyama M 1979 Sodium-dependent transport of l-leucine in membrane vesicles prepared from Pseudomonas aeruginosa. J Bacteriol 137:73–81.

    Not in our library10.1128/jb.137.1.73-81.1979

  159. 159.

    Hoshino T, Kageyama M 1980 Purification and properties of a binding protein for branched-chain amino acids in Pseudomonas aeruginosa. J Bacteriol 141:1055–1063.

    Not in our library10.1128/jb.141.3.1055-1063.1980

  160. 160.

    Hoshino T, Kose K 1990 Cloning, nucleotide sequences, and identification of products of the Pseudomonas aeruginosa PAO bra genes, which encode the high-affinity branched-chain amino acid transport system. J Bacteriol 172:5531–5539. doi:.

    Not in our library10.1128/jb.172.10.5531-5539.1990

  161. 161.

    Hoshino T, Kose K 1989 Cloning and nucleotide sequence of braC, the structural gene for the leucine-, isoleucine-, and valine-binding protein of Pseudomonas aeruginosa PAO. J Bacteriol 171:6300–6306. doi:.

    Not in our library10.1128/jb.171.11.6300-6306.1989

  162. 162.

    Uratani Y, Tsuchiya T, Akamatsu Y, Hoshino T 1989 Na+(Li+)/branched-chain amino acid cotransport in Pseudomonas aeruginosa. J Membr Biol 107:57–62. doi:.

    Not in our library10.1007/bf01871083

  163. 163.

    Ohnishi K, Kiritani K 1983 Purification and properties of two binding proteins for branched-chain amino acids in Salmonella typhimurium. J Biochem 94:433–441. doi:.

    Not in our library10.1093/oxfordjournals.jbchem.a134373

  164. 164.

    Ohnishi K, Nakazima A, Matsubara K, Kiritani K 1990 Cloning and nucleotide sequences of livB and liv, the structural genes encoding binding proteins of the high-affinity branched-chain amino acid transport in Salmonella typhimurium. J Biochem 107:202–208. doi:.

    Not in our library10.1093/oxfordjournals.jbchem.a123026

  165. 165.

    Matsubara K, Ohnishi K, Kiritani K 1992 Nucleotide sequences and characterization of liv genes encoding components of the high-affinity branched-chain amino acid transport system in Salmonella typhimurium. J Biochem 112:93–101. doi:.

    Not in our library10.1093/oxfordjournals.jbchem.a123872

  166. 166.

    Ohnishi K, Hasegawa A, Matsubara K, Date T, Okada T, Kiritani K 1988 Cloning and nucleotide sequence of the brnQ gene, the structural gene for a membrane-associated component of the LIV-II transport system for branched-chain amino acids in Salmonella typhimurium. Jpn J Genet 63:343–357. doi:.

    Not in our library10.1266/jjg.63.343

  167. 167.

    Ibberson CB, Jones CL, Singh S, Wise MC, Hart ME, Zurawski DV, Horswill AR 2014 Staphylococcus aureus hyaluronidase is a CodY-regulated virulence factor. Infect Immun 82:4253–4264. doi:.

    Not in our library10.1128/iai.01710-14

  168. 168.

    Geiger T, Goerke C, Fritz M, Schäfer T, Ohlsen K, Liebeke M, Lalk M, Wolz C 2010 Role of the (p)ppGpp synthase RSH, a RelA/SpoT homolog, in stringent response and virulence of Staphylococcus aureus. Infect Immun 78:1873–1883. doi:.

    Not in our library10.1128/iai.01439-09

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.